Safety, Pharmacokinetics, and Pharmacodynamics of CC‐90001 (BMS‐986360), a c‐Jun N‐terminal Kinase Inhibitor, in Phase 1 Studies in Healthy Participants.
Saved in:
| Title: | Safety, Pharmacokinetics, and Pharmacodynamics of CC‐90001 (BMS‐986360), a c‐Jun N‐terminal Kinase Inhibitor, in Phase 1 Studies in Healthy Participants. |
|---|---|
| Authors: | Ye, Ying1 (AUTHOR), Gaudy, Allison1 (AUTHOR), Thomas, Michael1 (AUTHOR), Reyes, Josephine1 (AUTHOR), Burkhardt, Barbara1 (AUTHOR), Horan, Gerald1 (AUTHOR), Liu, Liangang1 (AUTHOR), Chen, Jian1 (AUTHOR), Ghosh, Atalanta1 (AUTHOR), Carayannopoulos, Leonidas N.1 (AUTHOR), Tatosian, Daniel A.1 (AUTHOR) daniel.tatosian@bms.com, Palmisano, Maria1 (AUTHOR) |
| Source: | Clinical Pharmacology in Drug Development. Dec2022, Vol. 11 Issue 12, p1394-1404. 11p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
